418 related articles for article (PubMed ID: 19278896)
1. Targeting apoptosis as an approach for gastrointestinal cancer therapy.
Qiao L; Wong BC
Drug Resist Updat; 2009 Jun; 12(3):55-64. PubMed ID: 19278896
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targeting of apoptosis pathways in cancer.
Ziegler DS; Kung AL
Curr Opin Oncol; 2008 Jan; 20(1):97-103. PubMed ID: 18043263
[TBL] [Abstract][Full Text] [Related]
3. Overcoming apoptosis deficiency of melanoma-hope for new therapeutic approaches.
Eberle J; Kurbanov BM; Hossini AM; Trefzer U; Fecker LF
Drug Resist Updat; 2007 Dec; 10(6):218-34. PubMed ID: 18054518
[TBL] [Abstract][Full Text] [Related]
4. Novel targeted pro-apoptotic agents for the treatment of prostate cancer.
Huang X; Zhang X; Farahvash B; Olumi AF
J Urol; 2007 Nov; 178(5):1846-54. PubMed ID: 17868738
[TBL] [Abstract][Full Text] [Related]
5. Overcoming resistance of cancer cells to apoptosis.
Hersey P; Zhang XD
J Cell Physiol; 2003 Jul; 196(1):9-18. PubMed ID: 12767037
[TBL] [Abstract][Full Text] [Related]
6. Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy.
Maddika S; Ande SR; Panigrahi S; Paranjothy T; Weglarczyk K; Zuse A; Eshraghi M; Manda KD; Wiechec E; Los M
Drug Resist Updat; 2007; 10(1-2):13-29. PubMed ID: 17303468
[TBL] [Abstract][Full Text] [Related]
7. Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells.
Reuter S; Eifes S; Dicato M; Aggarwal BB; Diederich M
Biochem Pharmacol; 2008 Dec; 76(11):1340-51. PubMed ID: 18755156
[TBL] [Abstract][Full Text] [Related]
8. Directing cancer cells to self-destruct with pro-apoptotic receptor agonists.
Ashkenazi A
Nat Rev Drug Discov; 2008 Dec; 7(12):1001-12. PubMed ID: 18989337
[TBL] [Abstract][Full Text] [Related]
9. Exploiting apoptosis pathways for the treatment of pediatric cancers.
Fulda S
Pediatr Blood Cancer; 2009 Oct; 53(4):533-6. PubMed ID: 19148945
[TBL] [Abstract][Full Text] [Related]
10. Regulation of death receptors--relevance in cancer therapies.
de Thonel A; Eriksson JE
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):123-32. PubMed ID: 16126242
[TBL] [Abstract][Full Text] [Related]
11. Is TRAIL the holy grail of cancer therapy?
Newsom-Davis T; Prieske S; Walczak H
Apoptosis; 2009 Apr; 14(4):607-23. PubMed ID: 19194800
[TBL] [Abstract][Full Text] [Related]
12. Cell death in hematological tumors.
Fulda S
Apoptosis; 2009 Apr; 14(4):409-23. PubMed ID: 19130230
[TBL] [Abstract][Full Text] [Related]
13. The expressions of intrinsic and extrinsic apoptotic pathway proteins in neutrophils of oral cavity cancer patients: a preliminary study.
Jabłońska E; Garley M; Jabłoński J
Arch Immunol Ther Exp (Warsz); 2009; 57(3):229-34. PubMed ID: 19479204
[TBL] [Abstract][Full Text] [Related]
14. Small-molecule BH3 mimetics to antagonize Bcl-2-homolog survival functions in cancer.
Goldsmith KC; Hogarty MD
Curr Opin Investig Drugs; 2009 Jun; 10(6):559-71. PubMed ID: 19513945
[TBL] [Abstract][Full Text] [Related]
15. Novel ways to sensitise gastrointestinal cancer to apoptosis.
Schulze-Bergkamen H; Weinmann A; Moehler M; Siebler J; Galle PR
Gut; 2009 Jul; 58(7):1010-24. PubMed ID: 19520891
[TBL] [Abstract][Full Text] [Related]
16. Targeting programmed cell death pathways with experimental therapeutics: opportunities in high-risk neuroblastoma.
Goldsmith KC; Hogarty MD
Cancer Lett; 2005 Oct; 228(1-2):133-41. PubMed ID: 15927359
[TBL] [Abstract][Full Text] [Related]
17. Activation of p53/p21/PUMA alliance and disruption of PI-3/Akt in multimodal targeting of apoptotic signaling cascades in cervical cancer cells by a pentacyclic triterpenediol from Boswellia serrata.
Bhushan S; Malik F; Kumar A; Isher HK; Kaur IP; Taneja SC; Singh J
Mol Carcinog; 2009 Dec; 48(12):1093-108. PubMed ID: 19544329
[TBL] [Abstract][Full Text] [Related]
18. Survival and apoptotic signals in the action of microtubule-targeting antitumor drugs.
Mollinedo F
IDrugs; 2005 Feb; 8(2):127-43. PubMed ID: 15696415
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis and colorectal cancer: implications for therapy.
Yang SY; Sales KM; Fuller B; Seifalian AM; Winslet MC
Trends Mol Med; 2009 May; 15(5):225-33. PubMed ID: 19362056
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of anti-apoptotic Bcl-2 family members Mcl-1, Bcl-2, and Bcl-xL on celecoxib-induced apoptosis.
Rudner J; Elsaesser SJ; Müller AC; Belka C; Jendrossek V
Biochem Pharmacol; 2010 Jan; 79(1):10-20. PubMed ID: 19665451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
